Inventor
MICHAEL JOHN WRIGHT
Inventor
GB
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes21%
C12NMicroorganisms or enzymes10%
A01KAnimal husbandry7%
C07BGeneral methods of organic chemistry7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
12,473,355Gremlin-1 crystal structure and inhibitory antibody202512,331,117Antibody molecules which bind CD22202511,807,680Gremlin-1 crystal structure and inhibitory antibody202311,692,041Antibody molecules which bind CD45202311,472,879Antibody molecules which bind CD22202211,286,312Multispecific antibodies202211,261,252Molecules with specificity for CD79 and CD222022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UCB Biopharma SRL (7)· patent assignee history
2022–2023Patents assigned to UCB BIOPHARMA SPRL (2)· patent assignee history
2022–2025Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB Biopharma SRL | 7 | 2022–2025 |
| UCB BIOPHARMA SPRL | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 7 | 2022–2025 |